Statin safety and associated adverse events: a scientific statement from the American Heart Association

CB Newman, D Preiss, JA Tobert… - … , and vascular biology, 2019 - Am Heart Assoc
One in 4 Americans> 40 years of age takes a statin to reduce the risk of myocardial
infarction, ischemic stroke, and other complications of atherosclerotic disease. The most …

Statin-associated myopathy: emphasis on mechanisms and targeted therapy

P Vinci, E Panizon, LM Tosoni, C Cerrato… - International journal of …, 2021 - mdpi.com
Hyperlipidemia is a major risk factor for cardiovascular morbidity and mortality. Statins are
the first-choice therapy for dyslipidemias and are considered the cornerstone of …

Psoriasis and the metabolic syndrome

P Gisondi, AC Fostini, I Fossà, G Girolomoni… - Clinics in …, 2018 - Elsevier
Chronic plaque psoriasis is an immune-mediated inflammatory skin disease that is strongly
associated with the clinical features of the metabolic syndrome (MetS), including abdominal …

An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins

T Hirota, Y Fujita, I Ieiri - Expert Opinion on Drug Metabolism & …, 2020 - Taylor & Francis
Introduction Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) lower
cholesterol synthesis in patients with hypercholesterolemia. Increased statin exposure is an …

Update on colchicine, 2017

A Slobodnick, B Shah, S Krasnokutsky… - …, 2018 - academic.oup.com
Colchicine is an ancient medication that is currently approved for the treatment of gout and
FMF. However, colchicine has a wide range of anti-inflammatory activities, and studies …

Pharmacogenomics of drug metabolizing enzymes and transporters: relevance to precision medicine

S Ahmed, Z Zhou, J Zhou… - Genomics, proteomics and …, 2016 - academic.oup.com
The interindividual genetic variations in drug metabolizing enzymes and transporters
influence the efficacy and toxicity of numerous drugs. As a fundamental element in precision …

Membrane transporters in drug development

Nature reviews Drug discovery, 2010 - nature.com
Membrane transporters can be major determinants of the pharmacokinetic, safety and
efficacy profiles of drugs. This presents several key questions for drug development …

Statin-related myotoxicity: a comprehensive review of pharmacokinetic, pharmacogenomic and muscle components

RM Turner, M Pirmohamed - Journal of clinical medicine, 2019 - mdpi.com
Statins are a cornerstone in the pharmacological prevention of cardiovascular disease.
Although generally well tolerated, a small subset of patients experience statin-related …

OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies

M Roth, A Obaidat, B Hagenbuch - British journal of …, 2012 - Wiley Online Library
The human organic anion and cation transporters are classified within two SLC
superfamilies. Superfamily SLCO (formerly SLC21A) consists of organic anion transporting …

Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a …

BS Wiggins, JJ Saseen, RL Page, BN Reed, K Sneed… - Circulation, 2016 - Am Heart Assoc
A n D GUID eLIneS affordability may often dictate which medications may be prescribed.
Patients who have exhausted prescription drug coverage or who are uninsured may require …